Abstract:Abstract: Objective?To evaluate the safety and efficacy of en bloc transurethral resection of bladder tumor by 1470 nm laser in treatment of non-muscle-invasive bladder cancer.?Methods?The clinical data of 55 patients with bladder cancer received en bloc transurethral resection of bladder tumor by 1470 nm laser from October 2015 to February 2017 were analyzed. Preoperative cystoscopy was performed to confirm the location, numbers, size, and pedicle of the tumors. The preoperative clinical stages were TaN0M0 or T1N0M0. By using 1470 nm laser, the en bloc transurethral resection was performed until the deep muscularis or the adventitia layer. The intravesical instillation of pirarubicin was performed for one day postoperatively.?Results?All the patients underwent operations successfully, the operative time was 10 ~ 38 min (mean, 20 min). Flushing fluid color was constantly clear during operation. The obturator nerve reflex and perforation did not occur. All the patients had catheter indwelled for 3 ~ 7 days, and 5 ~ 8 days hospital stay after the operation. The pathological diagnosis was urothelial carcinoma. Postoperative pathological stages of enrolled cases were distributed as 23 cases of Ta staging, 31 cases of T1 staging, and one case of T2 staging. 55 cases were followed up for 6 ~ 30 months (mean, 15 months). The recurrence rate was 7.3% (4/55).?Conclusion?En bloc transurethral resection of bladder tumor by 1470 nm laser in the treatment of non-muscle-invasive bladder cancer is safe and effective, with comparatively complete specimens for pathological evaluation, it is worthy of clinical application.